Home > Healthcare > Medical Devices > Therapeutic Devices > Radiotherapy Market

Radiotherapy Market Trends

Report ID: GMI3539
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

Radiotherapy Market Trends

Advanced technologies, notably artificial intelligence (AI) and machine learning, are being integrated to enhance treatment plan precision and personalization.
The industry is witnessing a notable shift towards more accurate tumor targeting with the rise of image-guided radiotherapy (IGRT) and intensity-modulated radiotherapy (IMRT), which aim to minimize collateral damage to healthy tissues.
Proton therapy is gaining traction, especially for pediatric cancers and tumors near critical structures, due to its superior dose distribution precision. Hypofractionated radiotherapy, which administers higher doses in fewer sessions, is increasingly favored for its cost-effectiveness and convenience.
Moreover, heightened R&D investments are fueling innovations in radiotherapy equipment and techniques. Collaborations between healthcare providers and tech firms are driving the development of cutting-edge radiotherapy solutions, further fueling market growth.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The radiotherapy market size was valued at around USD 7 billion in 2023 and is estimated to record 5.7% CAGR from 2024 to 2032 owing to the increasing number of cancer cases globally.

The breast cancer segment in the market generated USD 2 billion in 2023 due to enhanced effectiveness, reduced side effects, and improving patient outcomes.

North America radiotherapy market is forecast to reach USD 4.1 billion by 2032 owing to the adoption of advanced medical technologies like proton therapy and state-of-the-art linear accelerators.

Accuray Incorporated, Brainlab AG, Curium, Canon Medical Systems Corporation, Elekta AB, Hitachi High-Tech Corporation, IBA Radiopharma Solutions, Isoray Inc., and Mevion Medical Systems among others.